Protective Immunity against Recurrent Staphylococcus aureus Skin Infection Requires Antibody and Interleukin-17A
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Although many microbial infections elicit an adaptive immune response that can protect against reinfection, it is generally thought that Staphylococcus aureus infections fail to generate protective immunity despite detectable T and B cell responses. No vaccine is yet proven to prevent S. aureus infections in humans, and efforts to develop one have been hampered by a lack of animal models in which protective immunity occurs. Our results describe a novel mouse model of protective immunity against recurrent infection, in which S. aureus skin and soft tissue infection (SSTI) strongly protected against secondary SSTI in BALB/c mice but much less so in C57BL/6 mice. This protection was dependent on antibody, because adoptive transfer of immune BALB/c serum or purified antibody into either BALB/c or C57BL/6 mice resulted in smaller skin lesions. We also identified an antibody-independent mechanism, because B cell-deficient mice were partially protected against secondary S. aureus SSTI and adoptive transfer of T cells from immune BALB/c mice resulted in smaller lesions upon primary infection. Furthermore, neutralization of interleukin-17A (IL-17A) abolished T cell-mediated protection in BALB/c mice, whereas neutralization of gamma interferon (IFN-γ) enhanced protection in C57BL/6 mice. Therefore, protective immunity against recurrent S. aureus SSTI was advanced by antibody and the Th17/IL-17A pathway and prevented by the Th1/IFN-γ pathway, suggesting that targeting both cell-mediated and humoral immunity might optimally protect against secondary S. aureus SSTI. These findings also highlight the importance of the mouse genetic background in the development of protective immunity against S. aureus SSTI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Klevens, R. M. (2007) · JAMA · doi:10.1001/jama.298.15.1763 · Cited by 3,726 · cited 3×
“CA-MRSA is now the leading cause of skin and soft tissue infections (SSTIs) in the United States, accounting for millions of patient visits per year (4–6).”
BackgroundInfluentialGenomic responses in mouse models poorly mimic human inflammatory diseases
Seok, J., Warren, H. S., Cuenca, A. G., Mindrinos, M. N., Baker, H. V., Xu, W., Richards, D. R., McDonald-Smith, G. P., Gao, H., Hennessy, L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222878110 · Cited by 3,005
Methicillin-Resistant S. aureus Infections among Patients in the Emergency Department
Moran, G. J., Krishnadasan, A., Gorwitz, R. J., Fosheim, G. E., McDougal, L. K., Carey, R. B., & Talan, D. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055356 · Cited by 2,285
David, M. Z., & Daum, R. S. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00081-09 · Cited by 1,972 · cited 1×
“An increasing percentage of MRSA infections occurs among previously healthy people without identified health care-associated risk factors, so called community-associated MRSA (CA-MRSA) infections (2, 3).”
BackgroundSelf-citationImpaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome
Milner, J. D., Brenchley, J. M., Laurence, A., Freeman, A. F., Hill, B. J., Elias, K. M., Kanno, Y., Spalding, C., Elloumi, H. Z., Paulson, M. L., et al. (2008) · Nature · doi:10.1038/nature06764 · Cited by 1,157
Ishigame, H., Kakuta, S., Nagai, T., Kadoki, M., Nambu, A., Komiyama, Y., Fujikado, N., Tanahashi, Y., Akitsu, A., Kotaki, H., et al. (2009) · Immunity · doi:10.1016/j.immuni.2008.11.009 · Cited by 1,004
IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice
Cho, J. S., Pietras, E. M., Garcia, N. C., Ramos, R. I., Farzam, D. M., Monroe, H. R., Magorien, J. E., Blauvelt, A., Kolls, J. K., Cheung, A. L., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40891 · Cited by 658 · cited 1×
“aureus skin and lung infections (13), as are mice that are deficient in IL-17 (14, 15).”
BackgroundKennedy, A. D., Wardenburg, J. B., Gardner, D. J., Long, D., Whitney, A. R., Braughton, K. R., Schneewind, O., & DeLeo, F. R. (2010) · The Journal of Infectious Diseases · doi:10.1086/656043 · Cited by 335
Progress Toward a Staphylococcus aureus Vaccine
Daum, R. S., & Spellberg, B. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir828 · Cited by 165
Self-citation
Cited by
Clinical Impact of Staphylococcus aureus Skin and Soft Tissue Infections
Linz, M. S., Mattappallil, A., Finkel, D., & Parker, D. (2023) · Antibiotics · doi:10.3390/antibiotics12030557 · Cited by 293
Isothiocyanates: An Overview of Their Antimicrobial Activity against Human Infections
Romeo, L., Iori, R., Rollin, P., Bramanti, P., & Mazzon, E. (2018) · Molecules · doi:10.3390/molecules23030624 · Cited by 230
Memory Th1 Cells Are Protective in Invasive Staphylococcus aureus Infection
Brown, A. F., Murphy, A. G., Lalor, S. J., Leech, J. M., O’Keeffe, K. M., Mac Aogáin, M., O’Halloran, D. P., Lacey, K. A., Tavakol, M., Hearnden, C. H., et al. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1005226 · Cited by 166
“It is likely that the nature of the infecting stain [26], and the site of infection significantly impact upon the nature of the T cell response elicited [27,28].”
BackgroundRegulatory T cells control Staphylococcus aureus and disease severity of cutaneous leishmaniasis
Singh, T. P., Farias Amorim, C., Lovins, V. M., Bradley, C. W., Carvalho, L. P., Carvalho, E. M., Grice, E. A., & Scott, P. (2023) · Journal of Experimental Medicine · doi:10.1084/jem.20230558 · Cited by 28
Brady, R. A., Bruno, V. M., & Burns, D. L. (2015) · PLOS ONE · doi:10.1371/journal.pone.0124877 · Cited by 24
“Whether this response is beneficial is debatable, as Montgomery and colleagues demonstrated that the TH1/IFNγ pathway prevented protective immunity in their model of SSTI [31], and Nippe et al.”
Background
Metadata
- Authors
- Montgomery, C. P., Daniels, M., Zhao, F., Alegre, M.-L., Chong, A. S., & Daum, R. S.
- Venue
- Infection and Immunity
- Publisher
- American Society for Microbiology
- Published
- 2014-05
- Volume
- 82
- Issue
- 5
- Pages
- 2125-2134
- ISSN
- 0019-9567 (ISSN-L)
- 1098-5522
- OpenAlex
- W2116714619
- Cited by
- 109
- References
- 9
- FWCI
- 8.65
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Protective Immunity against Recurrent Staphylococcus aureus Skin Infection Requires Antibody and Interleukin-17A. https://app.cochat.ai/papers/10.1128/iai.01491-14
- The paper
- Montgomery, C. P., Daniels, M., Zhao, F., Alegre, M.-L., Chong, A. S., & Daum, R. S. (2014). Protective Immunity against Recurrent Staphylococcus aureus Skin Infection Requires Antibody and Interleukin-17A. Infection and Immunity. https://doi.org/10.1128/iai.01491-14
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.